EGFR Antikörper (AA 344-492)
Kurzübersicht für EGFR Antikörper (AA 344-492) (ABIN6937129)
Target
Alle EGFR Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 344-492
-
Verwendungszweck
- EGFR (Epidermal Growth Factor Receptor) Antibody
-
Spezifität
- This MAb recognizes a protein of 170 kDa, identified as EGFR. EGFR is type I receptor tyrosine kinase with sequence homology to erbB-1, -2, -3 -4 or HER-1, -2, -3 -4. It binds to Epidermal Growth Factor (EGF), Transforming Growth Factor-a (TGF-a), Heparin-binding EGF (HB-EGF), amphiregulin, betacellulin and epiregulin. EGFR is overexpressed in tumors of breast, brain, bladder, lung, gastric, head neck, esophagus, cervix, vulva, ovary, and endometrium. It is predominantly present in squamous cell carcinomas.
-
Kreuzreaktivität (Details)
- Human.
-
Aufreinigung
- 200ug/ml of Ab Purified from Bioreactor Concentrate by Protein A/G.
-
Immunogen
- Recombinant fragment of human EGFR protein (around aa 344-492) (exact sequence is proprietary)
-
Isotyp
- IgG2b, kappa
-
-
-
-
Applikationshinweise
-
Known_Application: Flow Cytometry (1-2 μg/million cells), Immunofluorescence (1-2 μg/mL), Western Blot (1-2 μg/mL), Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT)(Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95°C followed by cooling at RT for 20 minutes), Optimal dilution for a specific application should be determined.
Positive_Control: A431 cells. Placenta, Breast, Colon or Bladder cancer.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 1.0 mg/mL
-
Buffer
- Prepared in 10 mM PBS
-
Konservierungsmittel
- Azide free
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.
-
Haltbarkeit
- 24 months
-
-
- EGFR (Epidermal Growth Factor Receptor (EGFR))
-
Andere Bezeichnung
- EGFR
-
Hintergrund
-
Erbb1, ERBB1, Errp, HER1, mENA, PIG61, Proto-oncogene c-ErbB-1, Receptor Tyrosine Protein Kinase, ErbB1, Urogastrone, wa2, Wa5
A431 cells. Placenta, Breast, Colon or Bladder cancer.
-
Molekulargewicht
- ~170kDa (wild type) and ~145kDa (vIII variant)
-
Gen-ID
- 1956, 488293
-
UniProt
- P00533
-
Pathways
- NF-kappaB Signalweg, RTK Signalweg, Fc-epsilon Rezeptor Signalübertragung, EGFR Signaling Pathway, Neurotrophin Signalübertragung, Stem Cell Maintenance, Hepatitis C, Positive Regulation of Response to DNA Damage Stimulus, Interaction of EGFR with phospholipase C-gamma, Thromboxane A2 Receptor Signaling, EGFR Downregulation, S100 Proteine
Target
-